Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Folate and global health review series, part 4: syntheses on folate and autoimmune diseases and skeletal outcomes.

Journal of global health·2026
Same author

Clinical characteristics associated with ischaemic stroke and transient ischaemic attack among non-anticoagulated patients with atrial fibrillation.

The New Zealand medical journal·2026
Same author

Statistical reviewing for a medical journal: summary of workshop proceedings.

Research integrity and peer review·2026
Same author

Variation in the use of electrical cardioversion and catheter ablation for atrial fibrillation/flutter according to sex and ethnicity in Aotearoa New Zealand.

The New Zealand medical journal·2026
Same author

Mechanisms of ischaemic strokes and transient ischaemic attacks despite oral anticoagulation in patients with atrial fibrillation.

The New Zealand medical journal·2026
Same author

PERKS-International: A Randomized Controlled Trial Testing the Efficacy of an mHealth Application to Reduce Risk Factors for the Primary Prevention of Stroke.

Stroke·2026
Same journal

Stroke Associated-Infections after Mechanical Thrombectomy: Analysis of the Stroke-Associated INfection afTer Mechanical Thrombectomy (SAINT-MT) study.

Cerebrovascular diseases extra·2026
Same journal

Rates, risks and routes to reduce vascular dementia (R4VaD), a UK-wide multicentre prospective observational cohort study of cognition after stroke: baseline data and statistical analysis plan (ISRCTN18274006).

Cerebrovascular diseases extra·2026
Same journal

Hypoperfusion Intensity Ratio as a Predictive Marker in Pre-Endovascular Treatment Perfusion MRI for Acute Middle Cerebral Artery Occlusion with Intracranial Atherosclerosis.

Cerebrovascular diseases extra·2026
Same journal

A Retrospective Study of Outcome Predictive Models for Anterior Circulation Stroke Post Endovascular Thrombectomy: Are CT-Derived Morphomics Useful?

Cerebrovascular diseases extra·2026
Same journal

Feasibility of DOAC Dipstick point-of-care testing in patients with acute stroke and transient ischemic attack.

Cerebrovascular diseases extra·2026
Same journal

Endovascular therapy for isolated M2 occlusion in patients with ischemic stroke: A propensity score-matched analysis.

Cerebrovascular diseases extra·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Demographic Refinement and Atrial Fibrillation Type in Stroke Risk Stratification Beyond CHA2DS2 VASc.

Karim M Mahawish, Rita V Krishnamurthi, Suzanne Barker-Collo

    Cerebrovascular Diseases Extra
    |July 2, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Demographic refinements offer little added value to the CHA2DS2 VASc score for predicting stroke in atrial fibrillation (AF) patients. Atrial fibrillation type modestly improves stroke risk prediction, especially in those not on anticoagulation.

    More Related Videos

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
    23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
    28:13

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

    Published on: February 26, 2013

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
    23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    Area of Science:

    • Cardiology
    • Stroke Prevention
    • Atrial Fibrillation Research

    Background:

    • The CHA2DS2 VASc score is standard for stroke risk in atrial fibrillation (AF).
    • Improving prediction with demographic factors has uncertain benefits, especially in diverse populations.
    • This study assesses if demographic changes or AF type enhance stroke risk prediction.

    Purpose of the Study:

    • To evaluate the incremental predictive value of demographic modifications and AF type.
    • To compare logistic regression models with the traditional CHA2DS2 VASc score.
    • To assess stroke risk stratification in a multi-ethnic AF population.

    Main Methods:

    • Retrospective case-control study of 1,908 AF patients.
    • Used CHA2DS2 VASc components, demographic factors, and AF type as predictors.
    • Assessed model discrimination using Area Under the Receiver Operating Characteristic Curve (AUC).

    Main Results:

    • Logistic regression with CHA2DS2 VASc predictors had AUC 0.68; traditional score had AUC 0.63.
    • Demographic refinements did not significantly improve discrimination (ΔAUC ≤0.01).
    • Adding AF type modestly increased discrimination (AUC 0.71; ΔAUC +0.03), particularly in non-anticoagulated patients.

    Conclusions:

    • Demographic refinements offer limited added value to CHA2DS2 VASc for stroke risk.
    • AF type provides a modest improvement in stroke risk discrimination.
    • Findings require external validation before clinical application.